Thrombolysis or Anticoagulation for Cerebral Venous Thrombosis (TOACT).

Trial Profile

Thrombolysis or Anticoagulation for Cerebral Venous Thrombosis (TOACT).

Discontinued
Phase of Trial: Phase II/III

Latest Information Update: 16 Feb 2017

At a glance

  • Drugs Alteplase (Primary) ; Urokinase (Primary) ; Heparin
  • Indications Intracranial thrombosis
  • Focus Therapeutic Use
  • Acronyms TO-ACT; TOACT
  • Most Recent Events

    • 11 Feb 2017 Planned End Date changed from 1 Jan 2018 to 1 Oct 2017.
    • 11 Feb 2017 Status changed from recruiting to discontinued.
    • 08 Nov 2011 New source identified and integrated (European Clinical Trials Database: EudraCT2010-020302-15).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top